Key result
Extended cold ischemic time linked to ~89% hospital survival in heart transplantation.
Why the study?
The outcomes of heart transplantation with extended cold ischemic time compared to short cold ischemic time were not well established.
Does extended cold ischemic time (>4 hours) reduce hospital survival in heart transplantation recipients compared to short cold ischemia time (<4 hours)?
Cohort (n=52)
No
Does extended cold ischemic time (>4 hours) reduce hospital survival in heart transplantation recipients compared to short cold ischemia time (<4 hours)?
Absolute Event Rate: 88.5% vs 80.7%
Extended cold ischemic time (>4 hours) during heart transplantation appears to have comparable hospital survival and postoperative outcomes to short cold ischemia time, though larger studies are needed.
Extended ischemia yielded similar short-term outcomes; small retrospective cohort leaves open prospective validation before wider use.
Aim. A retrospective analysis of the outcomes of heart transplantation (HT) with extended cold ischemic time of donor heart (more than 4 hours) versus heart transplantation with short cold ischemia time (less than 4 hours). Material and methods. The retrospective analysis included 52 recipients who underwent HT in the period from July 20, 2012 to October 23, 2019 in Meshalkin National Medical Research Center. The patients were divided into two groups: group 1 (n=26) — orthotopic HT with extended cold ischemic time (more than 240 minutes), group 2 (n=26) — short cold ischemia time (less than 240 minutes). The effect of cold ischemia duration on hospital survival, the function of donor heart, and the postoperative course was assessed. Results. A retrospective analysis revealed a higher rate of hospital survival in the group of recipients with extended cold ischemic time (more than 240 minutes) 88,5% compared to 80,7% in the second group. There was no difference between the groups in the acute rejection rate, the need for inotropic agents, mechanical circulatory support, and cardiac pacing, as well as the incidence of postoperative renal failure and infectious complications. Conclusion. Due to the small number of patients, our experience in HT with extended cold ischemic time does not allow us to draw global conclusions, but a preliminary comparison of HT with extended and short cold ischemic time did not reveal significant advantages in one group or another. This provides a basis for further accumulation of experience and research.
No takes yet. Share an insight, caveat, or question.
Fomichev et al. (2020) conducted a cohort in Heart transplantation (n=52). Extended cold ischemic time (>240 minutes) vs. Short cold ischemia time (<240 minutes) was evaluated on Hospital survival. Heart transplantation with extended cold ischemic time (>240 minutes) resulted in an 88.5% hospital survival rate compared to 80.7% with short cold ischemia time.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: